The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets
New datascope available in R2: open online Genomics Analysis and Visualization Platform ( https://r2.amc.nl ). "The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets" by Jaco Knol et. al under the guidance of Connie Jimenez published in Cancer Cell. "Most cancer proteomics studies to date have focused on a single cancer type. We report The Pan-Cancer Proteome Atlas (TPCPA) based on data-independent acquisition mass spectrometry, to better understand cancer biology and identify therapeutic targets and biomarkers. TPCPA includes 9,670 proteins derived from 999 primary tumors representing 22 cancer types. All TPCPA data can be queried in a dedicated web resource." The datascope can be acccessed here http://r2platform.com/TPCPA dataviz, proteomics, datascience, cancer